Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Methods Enzymol ; 342: 143-58, 2001.
Article in English | MEDLINE | ID: mdl-11586889

ABSTRACT

It is now evident that members of the RNase III family of nucleases have central roles in prokaryotic and eukaryotic RNA maturation and decay pathways. Ongoing research is uncovering new roles for RNase III homologs. For example, the phenomena of RNA interference (RNAi) and posttranscriptional gene silencing (PTGS) involve dsRNA processing, carried out by an RNase III homolog. We anticipate an increased focus on the mechanism, regulation, and biological roles of RNase III orthologs. Although the differences in the physicochemical properties of RNase III orthologs, and distinct substrate reactivity epitopes and ionic requirements for optimal activity, may mean that the protocols describe here are not strictly transferrable, the affinity purification methodology, and substrate preparation and use should be generally applicable.


Subject(s)
Endoribonucleases/isolation & purification , Escherichia coli Proteins , Escherichia coli/enzymology , Histidine/chemistry , Base Sequence , Electrophoresis, Polyacrylamide Gel , Endoribonucleases/chemistry , Endoribonucleases/metabolism , Hydrolysis , Molecular Sequence Data , Nucleic Acid Conformation , RNA/chemistry , Ribonuclease III , Substrate Specificity
2.
Nucleic Acids Res ; 29(9): 1915-25, 2001 May 01.
Article in English | MEDLINE | ID: mdl-11328875

ABSTRACT

Ethidium bromide (EB) is known to inhibit cleavage of bacterial rRNA precursors by Escherichia coli ribonuclease III, a dsRNA-specific nuclease. The mechanism of EB inhibition of RNase III is not known nor is there information on EB-binding sites in RNase III substrates. We show here that EB is a reversible, apparently competitive inhibitor of RNase III cleavage of small model substrates in vitro. Inhibition is due to intercalation, since (i) the inhibitory concentrations of EB are similar to measured EB intercalation affinities; (ii) substrate cleavage is not affected by actinomycin D, an intercalating agent that does not bind dsRNA; (iii) the EB concentration dependence of inhibition is a function of substrate structure. In contrast, EB does not strongly inhibit the ability of RNase III to bind substrate. EB also does not block substrate binding by the C-terminal dsRNA-binding domain (dsRBD) of RNase III, indicating that EB perturbs substrate recognition by the N-terminal catalytic domain. Laser photocleavage experiments revealed two ethidium-binding sites in the substrate R1.1 RNA. One site is in the internal loop, adjacent to the scissile bond, while the second site is in the lower stem. Both sites consist of an A-A pair stacked on a CG pair, a motif which apparently provides a particularly favorable environment for intercalation. These results indicate an inhibitory mechanism in which EB site-specifically binds substrate, creating a cleavage-resistant complex that can compete with free substrate for RNase III. This study also shows that RNase III recognition and cleavage of substrate can be uncoupled and supports an enzymatic mechanism of dsRNA cleavage involving cooperative but not obligatorily linked actions of the dsRBD and the catalytic domain.


Subject(s)
Endoribonucleases/metabolism , Enzyme Inhibitors/pharmacology , Escherichia coli Proteins , Escherichia coli/enzymology , Ethidium/pharmacology , RNA, Double-Stranded/metabolism , Base Sequence , Binding Sites , Dose-Response Relationship, Drug , Enzyme Inhibitors/chemistry , Ethidium/chemistry , Kinetics , Models, Chemical , Molecular Sequence Data , Nucleic Acid Conformation , Photochemistry , RNA, Double-Stranded/chemistry , Ribonuclease III
SELECTION OF CITATIONS
SEARCH DETAIL
...